Virulence and immunogenicity of galactose-resistant variants of Salmonella typhi Ty21a.
作者信息
Saxena M, Percheson P B, Di Fabio J L
出版信息
J Infect Dis. 1993 Aug;168(2):522-3. doi: 10.1093/infdis/168.2.522.
PMID:8336003
Abstract
摘要
相似文献
1
Virulence and immunogenicity of galactose-resistant variants of Salmonella typhi Ty21a.
J Infect Dis. 1993 Aug;168(2):522-3. doi: 10.1093/infdis/168.2.522.
2
Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.表达人乳头瘤病毒16型L1的伤寒沙门氏菌Typhi Ty21a作为预防宫颈癌和伤寒热的潜在活疫苗。
Clin Vaccine Immunol. 2007 Oct;14(10):1285-95. doi: 10.1128/CVI.00164-07. Epub 2007 Aug 8.
3
[Properties of 2 gal+ derivatives of the vaccine mutant gal E Ty21a strain of Salmonella typhi].
Bol Med Hosp Infant Mex. 1985 Apr;42(4):234-9.
4
Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.对口服伤寒沙门氏菌Ty21a疫苗和肠外Vi荚膜多糖伤寒疫苗同时接种的特异性和交叉反应性免疫应答。
Vaccine. 2015 Jan 9;33(3):451-8. doi: 10.1016/j.vaccine.2014.11.030. Epub 2014 Nov 26.
5
[The problem of designing typhoid vaccines].
Zh Mikrobiol Epidemiol Immunobiol. 1996 Jul-Aug(4):86-90.
6
Typhoid immunisation.伤寒免疫接种
Indian J Pediatr. 1984 Jan-Feb;51(408):71-6. doi: 10.1007/BF02753530.
7
Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa.伤寒Vi多糖疫苗在南非的疗效。
Vaccine. 1997 Feb;15(2):244. doi: 10.1016/s0264-410x(96)00168-5.
8
Vi Capsular Polysaccharide Produced by Recombinant Serovar Paratyphi A Confers Immunoprotection against Infection by Serovar Typhi.重组甲型副伤寒 Vi 荚膜多糖对伤寒血清型感染具有免疫保护作用。
Front Cell Infect Microbiol. 2017 Apr 24;7:135. doi: 10.3389/fcimb.2017.00135. eCollection 2017.
9
A Salmonella typhi Vi conjugate vaccine.一种伤寒Vi结合疫苗。
N Engl J Med. 2001 Aug 16;345(7):545-6. doi: 10.1056/NEJM200108163450713.
10
Typhoid fever--important issues still remain.伤寒热——重要问题依然存在。
Trends Microbiol. 1998 Apr;6(4):131-3. doi: 10.1016/s0966-842x(98)01236-0.
Zotero 插件